Bleeding Management Masterclass

Thank you Dr. @petrosoniak, Dr. Andrew Shih, Dr. Christine Cserti-Gazdewich, Dr. @MeffeFilomena, Dr. Jeannie Callum, @nour_homsi, Dr. Oksana Prokopchuk-Gauk, Dr. Omar Dabash, Dr. Sam Schulman, Dr. @SAM_UTOR, Dr. Tyler James, Dr. @ZiadSolh for your valuable contributions to the platform.

𝗛𝗼𝘄 𝗱𝗼 𝘄𝗲 𝘁𝘂𝗿𝗻 𝗻𝗲𝘄 𝗯𝗹𝗲𝗲𝗱𝗶𝗻𝗴 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻𝘁𝗼 𝗯𝗲𝘁𝘁𝗲𝗿 𝗰𝗮𝗿𝗲, 𝗳𝗮𝘀𝘁𝗲𝗿? That’s the question that led to 🩸Treat the Bleed. This expert-led education platform is co-created by Canada’s transfusion medicine leaders to help clinicians stay current, test their knowledge, and translate evidence into everyday decisions. We are proud to support this initiative through an unrestricted educational grant, and grateful to the contributors who’ve shaped it into a trusted teaching tool across hospitals and training programs. 👉 Have you joined yet? treatthebleed.org #TransfusionMedicine #BleedingManagement #EvidenceToPractice

Study Results Reveal Game-Changing Efficacy & Safety of Octaplex® (4F-PCC) in Cardiac Surgery. BREAKING: #FARESII trial results are out! Octaplex® (4F-PCC) is SUPERIOR to Frozen Plasma (FP) in cardiac surgery bleeding management! 🔹 Hemostatic efficacy: 17.6% improvement vs. FP 🔹 1.8x lower hemostatic failure rate than FP 🔹 No increased thromboembolic risk 🔹 Reduces need for transfusion of RBCs and Platelets Today, Dr. @KeyvanKarkouti, lead investigator of the FARES-II trial presented the study and findings at ACC in Chicago. This is #PatientBloodManagement (PBM) in action—redefining bleeding treatment protocols globally! Time for #TransfusionMedicine specialists & policymakers to update protocols and improve patient outcomes! 🔗 Read the full study in @JAMA_current : hubs.ly/Q03f0j5k0 🔗 Learn more on the trials impact to PBM, including a quote from the co-investigator, Dr. @JeannieCallum octapharma.ca/en/news/press-… #FARESII #CardiacSurgery #4FPCC #BleedingManagement #PBM #MedicalInnovation